In this webinar, we will discuss the clinical differences and administration considerations between Bicillin LA and Lentocilin. This webinar will explore the practical implications of using Lentocilin in clinical settings, including real-world experiences and insights from the field.
Class Objectives:
· Describe the key differences between Bicillin L-A and Lentocilin for the treatment of syphilis, including formulation, dosing, administration, and clinical considerations.
· Apply current evidence-based guidelines to clinical decision-making and patient management.
· Implement recommended treatment protocols, including medication administration and follow-up care.
· Integrate patient-centered communication strategies into clinical practice.
· Recognize barriers to care and develop strategies to improve patient outcomes and workflow efficiency.
Date: Wednesday, May 6, 2026
Time Zones:
12:00 PM PT
1:00 PM MT
2:00 PM CT
3:00 PM ET
Location : Zoom link will be in confirmation email after you have registered.
In support of improving patient care, this activity has been planned and implemented by the UAB Marnix E. Heersink School of Medicine and the Denver Prevention Training Center. The UAB Marnix E. Heersink School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
The UAB Heersink School of Medicine designates this educational activity for a maximum of ONE AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nexi Sanchez
nexi.sanchezvillalobos@dhha.org